Latest News


Filter by tags: Helium-4 Clear all tag filters

1 news articles found

US company to build a proposed medical isotope facility in Janesville, WI The US nuclear regulator has published in the Federal Register a notice of opportunity for submissions regarding a “first of a kind” application by Shine Medical Technologies to operate a proposed medical isotope production facility that does not require a nuclear reactor.

The Nuclear Regulatory Commission said submissions must be filed by 10 March 2020 by anyone who wishes to participate in the hearing process for the application.

Shine has proposed to construct and operate a facility in Janesville, Wisconsin for the production of the radioisotope molybdenum-99 (Mo-99) through the irradiation and processing of a uranyl sulfate solution. The company said this patented process replaces a nuclear reactor with a low-energy, accelerator-based neutron source. 

This source functions by colliding deuterium ions with tritium gas to cause fusion. The fusion reaction results in high energy neutrons and helium-4. In other words, the accelerator takes a radioactive by-product created by nuclear power plants (tritium) and turns it into the same clean, harmless gas used to make balloons float.

Date: Wednesday, 15 January 2020
Original article:



No Tags found.